Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine (Journal of Psychopharmacology (February 28, 2008) 22:7 DOI 10.1177/0269881106082899);Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine

Journal of Psychopharmacology

Volumn 22, Issue 7, 2008, Pages 784-791

  Feng, P ^a,b,c   Vurbic, D ^a,c   Wu, Z ^a,c   Hu, Y ^a,c   Strohl, K P ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

Clomipramine; Depression; Hypocretin; Orexin; Rat

Indexed keywords

CLOMIPRAMINE; OREXIN; OREXIN A; OREXIN B; SODIUM CHLORIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DEPRESSION; DISEASE MODEL; FORCED SWIMMING TEST; HYPOTHALAMUS; IMMOBILIZATION; LONG EVANS CINNAMON RAT; MALE; NEWBORN; NEWBORN PERIOD; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT;

EID: 50249149817     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108099059     Document Type: Erratum

References (54)

1. Allard J.S., Tizabi Y., Shaffery J.P., Trouth C.O., Manaye K. (2004) Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression. Neuropeptides 38: 311-315
2. Arango V., Underwood M.D., Gubbi A.V., Mann J.J. (1995) Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 688: 121-133
3. Arango V., Ernsberger P., Marzuk P.M., Chen J.S., Tierney H., Stanley M., Reis D.J., Mann J.J. (1990) Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 47: 1038-1047
4. Becker PM (2006) Treatment of sleep dysfunction and psychiatric disorders. Curr Treat Options Neurol 8: 367-375
5. Boldrini M., Underwood M.D., Mann J.J., Arango V. (2005) More tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides. Brain Res 1041: 19-28
6. Bonilla-Jaime H., Retana-Marquez S., Velazquez-Moctezuma J. (1998) Pharmacological features of masculine sexual behavior in an animal model of depression. Pharmacol Biochem Behav 60: 39-45
7. Brower K.J. (2003) Insomnia, alcoholism and relapse. Sleep Med Rev 7: 523-539
8. Brown R.E., Sergeeva O.A., Eriksson K.S., Haas H.L. (2002) Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/ hypocretin, histamine and noradrenaline). J Neurosci 22: 8850-8859
9. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S. 2nd, Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95: 322-327
10. Dwivedi Y., Rizavi H.S., Roberts R.C., Conley R.C., Tamminga C.A., Pandey G.N. (2001) Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 77: 916-928
11. Dwyer S.M., Rosenwasser A.M. (1998) Neonatal clomipramine treatment, alcohol intake and circadian rhythms in rats. Psychopharmacology (Berl) 138: 176-183
12. Espana R.A., Baldo BA, Kelley A.E., Berridge C.W. (2001) Wake-promoting and sleep-suppressing actions of hypocretin (orexin). basal forebrain sites of action. Neuroscience 106: 699-715
13. Fava M. (2004) Daytime sleepiness and insomnia as correlates of depression. J Clin Psychiatry 65 (Suppl. 16). 27-32
14. Feenstra M.G., van Galen H., Te Riele P.J., Botterblom M.H., Mirmiran M. (1996) Decreased hypothalamic serotonin levels in adult rats treated neonatally with clomipramine. Pharmacol Biochem Behav 55: 647-652
15. Feng P., Ma Y., Vogel G.W. (2001) The critical window of brain development from susceptive to insusceptive. Effects of clomipramine neonatal treatment on sexual behavior. Brain Res Dev Brain Res 129: 107-110
16. Feng P., Guan Z., Yang X., Fang J. (2003) Impairments of ERK signal transduction in the brain in a rat model of depression induced by neonatal exposure of clomipramine. Brain Res 991: 195-205
17. Feng P., Vurbic D., Wu Z., Strohl K.P. (2007) Brain orexins and wake regulation in rats exposed to maternal deprivation. Brain Res 1154C: 163-172
18. Hilakivi L.A., Sinclair J.D., Hilakivi I.T. (1984) Effects of neonatal treatment with clomipramine on adult ethanol related behavior in the rat. Brain Res 317: 129-132
19. Hilakivi L.A., Taira T., Hilakivi I., Loikas P. (1988) Neonatal treatment with monoamine uptake inhibitors alters later response in behavioural 'despair' test to beta and GABA-B receptor agonists. Pharmacol Toxicol 63: 57-61
20. Hrdina P.D., Demeter E., Vu T.B., Sotonyi P., Palkovits M. (1993) 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/ depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res 614: 37-44
21. Kinney G.G., Vogel G.W., Feng P. (1997) Decreased dorsal raphe nucleus neuronal activity in adult chloral hydrate anesthetized rats following neonatal clomipramine treatment: implications for endogenous depression. Brain Res 756: 68-75
22. Lam R.W. (2006) Sleep disturbances and depression: a challenge for antidepressants. Int Clin Psychopharmacol 21 (Suppl. 1). S25 - S29
23. Li Y., van den Pol A.N. (2005) Direct and indirect inhibition by catecholamines of hypocretin/orexin neurons. J Neurosci 25: 173-183
24. Lin L., Wisor J., Shiba T., Taheri S., Yanai K., Wurts S., Lin X., Vitaterna M., Takahashi J., Lovenberg T.W., Koehl M., Uhl G., Nishino S., Mignot E. (2002) Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic background. Peptides 23: 2203-2211
25. Liu R.J., van den Pol A.N., Aghajanian G.K. (2002) Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J Neurosci 22: 9453-9464
26. Mann J.J., Huang Y.Y., Underwood M.D., Kassir S.A., Oppenheim S., Kelly T.M., Dwork A.J., Arango V. (2000) A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57: 729-738
27. Martins P.J., D'Almeida V., Pedrazzoli M., Lin L., Mignot E., Tufik S. (2004) Increased hypocretin-1 (orexin-a) levels in cerebrospinal fluid of rats after short-term forced activity. Regul Pept 117: 155-158
28. Maudhuit C., Hamon M., Adrien J. (1996) Effects of chronic treatment with zimelidine and REM sleep deprivation on the regulation of raphe neuronal activity in a rat model of depression. Psychopharmacology (Berl) 124: 267-274
29. Mirmiran M., van de Poll N.E., Corner M.A., van Oyen H.G., Bour H.L. (1981) Suppression of active sleep by chronic treatment with chlorimipramine during early postnatal development: effects upon adult sleep and behavior in the rat. Brain Res 204: 129-146
30. Mirmiran M., Scholtens J., van de Poll N.E., Uylings H.B., van der Gugten J., Boer G.J. (1983) Effects of experimental suppression of active (REM) sleep during early development upon adult brain and behavior in the rat. Brain Res 283: 277-286
31. Muraki Y., Yamanaka A., Tsujino N., Kilduff T.S., Goto K., Sakurai T. (2004) Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor. J Neurosci 24: 7159-7166
32. Neill D., Vogel G., Hagler M., Kors D., Hennessey A. (1990) Diminished sexual activity in a new animal model of endogenous depression. Neurosci Biobehav Rev 14: 73-76
33. Nestler E.J., Gould E., Manji H., Buncan M., Duman R.S., Greshenfeld H.K., Hen R., Koester S., Lederhendler I., Meaney M., Robbins T., Winsky L., Zalcman S. (2002) Preclinical models: status of basic research in depression. Biol Psychiatry 52: 503-528
34. Pandey G.N., Dwivedi Y., Rizavi H.S., Ren X., Pandey S.C., Pesold C., Roberts R.C., Conley R.R., Tamminga C.A. (2002) Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 159: 419-429
35. Riemann D., Voderholzer U. (2003) Primary insomnia: a risk factor to develop depression? J Affect Disord 76: 255-259
36. Riemann D., Voderholzer U., Berger M. (2002) Sleep and sleep-wake manipulations in bipolar depression. Neuropsychobiology 45 (Suppl. 1). 7-12
37. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richarson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 1 page following 696
38. Salin-Pascual R.J. (2002) Relationship between mood improvement and sleep changes with acute nicotine administration in non-smoking major depressed patients. Rev Invest Clin 54: 36-40
39. Salomon R.M., Ripley B., Kennedy J.S., Johnson B., Schmidt D., Zeitzer J.M., Nishino S., Mignot E. (2003) Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol Psychiatry 54: 96-104
40. Torterolo P., Yamuy J., Sampogna S., Morales F.R., Chase M.H. (2003) Hypocretinergic neurons are primarily involved in activation of the somatomotor system. Sleep 26: 25-28
41. Trivedi P., Yu H., MacNeil D.J., Van der Ploeg L.H., Guan X.M. (1998) Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 438: 71-75
42. Tsuno N., Besset A., Ritchie K. (2005) Sleep and depression. J Clin Psychiatry 66: 1254-1269
43. Velazquez-Moctezuma J., Diaz Ruiz O. (1992) Neonatal treatment with clomipramine increased immobility in the forced swim test: an attribute of animal models of depression. Pharmacol Biochem Behav 42: 737-739
44. Velazquez-Moctezuma J., Aguilar-Garcia A., Diaz-Ruiz O. (1993) Behavioral effects of neonatal treatment with clomipramine, scopolamine, and idazoxan in male rats. Pharmacol Biochem Behav 46: 215-217
45. Vijayakumar M., Meti B.L. (1999) Alterations in the levels of monoamines in discrete brain regions of clomipramine-induced animal model of endogenous depression. Neurochem Res 24: 345-349
46. Vogel G.W. (1975) A review of REM sleep deprivation. Arch Gen Psychiatry 32: 749-761
47. Vogel G.W., Vogel F.A. (1982) A new animal model of human endogenous depression. Sleep Research 11: 222
48. Vogel G.W., Traub A.C., Ben-Horin P., Meyers G.M. (1968) REM deprivation. II. The effects on depressed patients. Arch Gen Psychiatry 18: 301-311
49. Vogel G., Neill D., Kors D., Hagler M. (1990 a) REM sleep abnormalities in a new animal model of endogenous depression. Neurosci Biobehav Rev 14: 77-83
50. Vogel G., Neill D., Hagler M., Kors D. (1990 b) A new animal model of endogenous depression: a summary of present findings. Neurosci Biobehav Rev 14: 85-91
51. Vogel G., Neill D., Hagler M., Kors D., Hartley P. (1990 c) Decreased intracranial self-stimulation in a new animal model of endogenous depression. Neurosci Biobehav Rev 14: 65-68
52. West C.H., Weiss J.M. (1998) Effects of antidepressant drugs on rats bred for low activity in the swim test. Pharmacol Biochem Behav 61: 67-79
53. Wilson S., Argyropoulos S. (2005) Antidepressants and sleep: a qualitative review of the literature. Drugs 65: 927-947
54. Winsky-Sommerer R., Yamanaka A., Diano S., Borok E., Roberts A.J., Sakurai T., Kilduff T.S., Horvath T.L., de Lecea L. (2004) Interaction between the corticotropin-releasing factor system and hypocretins (orexins). a novel circuit mediating stress response. J Neurosci 24: 11439-11448